Wikidata entity: Q414143
C₉H₁₁F₂N₃O₄ (P274)
Quantities
| P2067 | mass | 263.072 |
| P3780 | active ingredient in | ... | Q47521647 (Gemzar) | Gemzar |
| P233 | canonical SMILES | String | C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F | ??? |
| P972 | catalog | ... | Q90481889 (CAS COVID-19 Anti-Viral Candidate Compounds) | CAS COVID-19 Anti-Viral Candidate Compounds |
| P373 | Commons category | String | Gemcitabine | ??? |
| P1889 | different from | ... | Q27096024 (4-amino-1-(2-deoxy-2,2-difluoro-D-erythro-pentofuranosyl)-2(1H)-pyrimidinone) | 4-amino-1-(2-deoxy-2,2-difluoro-D-erythro-pentofuranosyl)-2(1H)-pyrimidinone |
| P703 | found in taxon | ... | Q10420084 (Aspergillus violaceofuscus) | Aspergillus violaceofuscus |
| P703 | found in taxon | ... | Q10622888 (Penicillium brocae) | Penicillium brocae |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2017 | isomeric SMILES | String | C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F | ??? |
| P8026 | LiverTox likelihood score | ... | Q83284310 (LiverTox toxicity likelihood category C) | LiverTox toxicity likelihood category C |
| P176 | manufacturer | ... | Q206921 (Pfizer) | Pfizer |
| P2175 | medical condition treated | ... | Q208414 (lymphoma) | lymphoma |
| P2175 | medical condition treated | ... | Q1671685 (invasive ductal carcinoma) | invasive ductal carcinoma |
| P2175 | medical condition treated | ... | Q1891209 (mycosis fungoides) | mycosis fungoides |
| P2175 | medical condition treated | ... | Q2501186 (transitional cell carcinoma) | transitional cell carcinoma |
| P2175 | medical condition treated | ... | Q2626074 (diffuse large B-cell lymphoma) | diffuse large B-cell lymphoma |
| P2175 | medical condition treated | ... | Q3658562 (non-small-cell lung carcinoma) | non-small-cell lung carcinoma |
| P2175 | medical condition treated | ... | Q5749020 (squamous cell carcinoma of the lung) | squamous cell carcinoma of the lung |
| P2175 | medical condition treated | ... | Q8263002 (pancreatic ductal carcinoma) | pancreatic ductal carcinoma |
| P2175 | medical condition treated | ... | Q1138590 (non-Hodgkin lymphoma) | non-Hodgkin lymphoma |
| P2175 | medical condition treated | ... | Q123750979 (low-grade serous carcinoma) | low-grade serous carcinoma |
| P2175 | medical condition treated | ... | Q504775 (bladder cancer) | bladder cancer |
| P2175 | medical condition treated | ... | Q18556189 (pancreatic adenocarcinoma) | pancreatic adenocarcinoma |
| P2175 | medical condition treated | ... | Q18556721 (uterus leiomyosarcoma) | uterus leiomyosarcoma |
| P2175 | medical condition treated | ... | Q18556933 (cribriform carcinoma) | cribriform carcinoma |
| P2175 | medical condition treated | ... | Q28757362 (tongue squamous cell carcinoma) | tongue squamous cell carcinoma |
| P2175 | medical condition treated | ... | Q56014224 (carcinoma of gallbladder and extrahepatic biliary tract) | carcinoma of gallbladder and extrahepatic biliary tract |
| P2175 | medical condition treated | ... | Q56014469 (bone sarcoma) | bone sarcoma |
| P2175 | medical condition treated | ... | Q11611688 (bile duct carcinoma) | bile duct carcinoma |
| P2175 | medical condition treated | ... | Q18348812 (head and neck squamous cell carcinoma) | head and neck squamous cell carcinoma |
| P2175 | medical condition treated | ... | Q18553445 (mature T-cell and NK-cell lymphoma) | mature T-cell and NK-cell lymphoma |
| P2175 | medical condition treated | ... | Q18555254 (germ cell cancer) | germ cell cancer |
| P2175 | medical condition treated | ... | Q18556148 (bladder urothelial carcinoma) | bladder urothelial carcinoma |
| P361 | part of | ... | Q22274454 (response to gemcitabine) | response to gemcitabine |
| P129 | physically interacts with | ... | Q21108338 (Ribonucleotide reductase regulatory subunit M2) | Ribonucleotide reductase regulatory subunit M2 |
| P129 | physically interacts with | ... | Q21121233 (Ribonucleotide reductase catalytic subunit M1) | Ribonucleotide reductase catalytic subunit M1 |
| P3489 | pregnancy category | ... | Q3679274 (Australian pregnancy category D) | Australian pregnancy category D |
| P3489 | pregnancy category | ... | Q28123618 (US pregnancy category D) | US pregnancy category D |
| P6802 | related image | CommonsMedia | http://commons.wikimedia.org/wiki/Special:FilePath/Gemcitabine%20Synthesis.png | ??? |
| P279 | subclass of | ... | Q27096024 (4-amino-1-(2-deoxy-2,2-difluoro-D-erythro-pentofuranosyl)-2(1H)-pyrimidinone) | 4-amino-1-(2-deoxy-2,2-difluoro-D-erythro-pentofuranosyl)-2(1H)-pyrimidinone |
| P2868 | subject has role | ... | Q35456 (essential medicine) | essential medicine |
| P2868 | subject has role | ... | Q2126468 (radiosensitizer) | radiosensitizer |
| P2868 | subject has role | ... | Q4118287 (DNA polymerase inhibitors) | DNA polymerase inhibitors |
| P2868 | subject has role | ... | Q846227 (antiviral drug) | antiviral drug |
| P2868 | subject has role | ... | Q804539 (bactericide) | bactericide |
| P2868 | subject has role | ... | Q249619 (immunosuppressive drug) | immunosuppressive drug |
| P2868 | subject has role | ... | Q427492 (enzyme inhibitor) | enzyme inhibitor |
| P2868 | subject has role | ... | Q40207875 (antiviral agent) | antiviral agent |
| P2868 | subject has role | ... | Q50429867 (antineoplastic antimetabolite) | antineoplastic antimetabolite |
Why not click here or view trends?
log id: None